Showing results (481-490 of 524) with videos related to

Sort By:
Pageof 53
Human Brain Mapping|March 19, 2016
Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniquesRocco Marchitelli, Ludovico Minati, Moira Marizzoni, et al.
Annals of the New York Academy of Sciences|January 27, 2026
Periodic and Aperiodic Electroencephalographic Rhythms During Vigilance Transitions in Alzheimer's Disease Mild Cognitive ImpairmentMatteo Carpi, Veronica Henao Isaza, Giuseppe Noce, et al.
Neurobiology of Aging|March 23, 2015
Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: a European early-onset dementia consortium studyElise Cuyvers, Julie van der Zee, Karolien Bettens, et al.
Genome Medicine|October 4, 2023
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioningAlexander Neumann, Olena Ohlei, Fahri Küçükali, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 1, 2020
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohortDaniel Stamate, Min Kim, Petroula Proitsi, et al.
Human Brain Mapping|June 6, 2015
Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderlyMoira Marizzoni, Luigi Antelmi, Beatriz Bosch, et al.
Neuroimage|May 17, 2020
Amygdalar nuclei and hippocampal subfields on MRI: Test-retest reliability of automated volumetry across different MRI sites and vendorsGiulia Quattrini, Michela Pievani, Jorge Jovicich, et al.
Geroscience|May 21, 2026
Abnormal periodic and aperiodic resting-state electroencephalographic markers in Lewy body and Alzheimer's diseases with cognitive declineMatteo Carpi, Antonio Pio Afragola, Mina De Bartolo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 9, 2026
Revising the ABIDE MCI to dementia prediction model for automated cerebrospinal fluid assaysPieter J van der Veere, Argonde C van Harten, Ingrid S van Maurik, et al.
JAMA Neurology|November 2, 2016
Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) StudyMarina Boccardi, Daniele Altomare, Clarissa Ferrari, et al.
Pageof 53